Phase 1 Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Part A (Healthy Volunteers):
- You are considered to be in good general health, based on your medical history, physical check-up, and test results at the start of the study
- Your Body Mass Index (BMI — a measure of body weight relative to height) is between 18 and 31 at the start of the study
Part B (Atopic Dermatitis Patients):
- You have had atopic dermatitis (eczema) for at least 6 months before joining the study
- Your eczema severity score (called EASI) is 5 or above at both your initial and baseline appointments (confirm with trial site)
- Your overall skin condition rating (called IGA) is 2 or above at both your initial and baseline appointments (confirm with trial site)
Who may not be able to join:
Part A (Healthy Volunteers):
- You were admitted to hospital for more than 24 hours for any reason within the 30 days before your first appointment
- You have a known allergy or sensitivity to the study treatment or any of its ingredients
- You have a history of a parasitic infection, except for trichomoniasis that has been fully treated
- You received a live vaccine within 1 month before your first appointment, or expect to need one during the study
- You have a history of alcohol or drug misuse, as judged by the study doctor
Part B (Atopic Dermatitis Patients):
- You have a known or suspected history of a weakened immune system
- You have other skin conditions that could affect how the study results are measured
- You are unable to stop certain medications or treatments before and during the study, as outlined by the study rules (confirm with trial site)
- You have an ongoing long-term health condition that is not well controlled and may require short courses of steroid tablets during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Trial Management, Regeneron Pharmaceuticals
Phone: 844-734-6643
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Occurrence of Treatment Emergent Adverse Events (TEAEs); Severity of TEAEs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.